Final Trial Results Confirm Disappointment on CureVac Vaccine - The New York Times
- Final Trial Results Confirm Disappointment on CureVac Vaccine The New York Times
- CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result The Washington Post
- UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout Yahoo Finance
- German COVID-19 vaccine CureVac has efficacy rate of 48 percent in final trials Firstpost
- Coronavirus digest: Curevac jab only 48% effective across age groups DW (English)
- View Full Coverage on Google News
source https://news.google.com/__i/rss/rd/articles/CBMiR2h0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMDYvMzAvc2NpZW5jZS9jdXJldmFjLXZhY2NpbmUtcmVzdWx0cy5odG1s0gFLaHR0cHM6Ly93d3cubnl0aW1lcy5jb20vMjAyMS8wNi8zMC9zY2llbmNlL2N1cmV2YWMtdmFjY2luZS1yZXN1bHRzLmFtcC5odG1s?oc=5
Comments
Post a Comment